{"symbol": "KTOV", "name": "Kitov Pharma", "next_earnings_utc": 1592909700, "next_earnings_period_start_date_utc": 1585612800, "next_earnings_period_end_date_utc": 1593475200, "next_earnings_has_time": true, "next_earnings_name": "2020 Q2", "next_earnings_year": 2020, "next_earnings_quarter": 2, "next_earnings_revenue_num_analysts": null, "next_earnings_revenue_consensus": 2286000.0, "next_earnings_eps_num_analysts": null, "next_earnings_eps_consensus": -0.06, "eps_up_revisions": null, "eps_down_revisions": null, "revenue_up_revisions": null, "revenue_down_revisions": null, "total_analysts": 0, "analysts_sell": null, "analysts_buy": null, "analysts_outperform": null, "analysts_hold": null, "analysts_underperform": null, "webpage": "kitovpharma.com", "year_founded": 2010, "street_address": "One Azrieli Center", "city": "Tel Aviv", "state": null, "zipcode": "6701101", "country": "Israel", "phone_number": "972 3 933 3121", "short_description": "Kitov Pharma Ltd, through its subsidiaries, operates as a development stage biopharmaceutical company in Israel.", "long_description": "Kitov Pharma Ltd, through its subsidiaries, operates as a development stage biopharmaceutical company in Israel. The company operates through two segments, Pain and Hypertension; and Oncology. It develops combination drugs for the simultaneous treatment of pain caused by osteoarthritis and hypertension. The company\u00e2\u20ac\u2122s lead drug candidate is Consensi a combination of APIs celecoxib and amlodipine besylate. It is also developing NT219, a small molecule that targets two oncology-related proteins to overcome resistance to cancer drug treatment. The company was formerly known as Kitov Pharmaceuticals Holdings Ltd. and changed its name to Kitov Pharma Ltd in January 2018. Kitov Pharma Ltd was founded in 2010 and is headquartered in Tel Aviv, Israel.", "industry_name": "Pharmaceuticals", "sector_name": "Health Care", "is_defunct": false, "exchange": "NASDAQ", "equity_type": "stocks", "market_cap": 45799215, "total_enterprise": 42088528, "number_of_employees": 9, "outstanding_shares": 95551569, "eps": -0.302052, "diluted_eps": -0.302052, "earnings_from_cont_operations": -5893000, "gross_profit": 1000000, "cash": 4395000, "total_debt": 223000, "total_revenue": 1000000, "cash_from_operations": -5581000, "net_income": -5850000, "ebitda": -6790000, "year_low_stock_price": 0.22, "year_high_stock_price": 1.08, "seekingalpha_follower_count": 3994, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/KTOV.png"}